Research programme: cyclo-oxygenase-2 inhibitors - FAES

Drug Profile

Research programme: cyclo-oxygenase-2 inhibitors - FAES

Alternative Names: COX-2 inhibitors research programme - FAES; Cyclo-oxygenase-2 inhibitors research programme - FAES; Research programme: COX-2 inhibitors - FAES

Latest Information Update: 23 Mar 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator FAES Farma
  • Class
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Inflammation

Most Recent Events

  • 06 Sep 2004 Data presented at the XVIIIth International Symposium on Medicinal Chemistry (ISMC-2004) have been added to the Inflammation pharmacodynamics section
  • 14 Sep 2001 This programme is still in active development
  • 22 Sep 1999 Preclinical development for Inflammation in Spain (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top